ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ÕÅÁ¦ÍŶÓΪ»¯ÁÆ»¼Õß´øÀ´Ö¹ÍÂÐÂÑ¡Ôñ

¸å¼þȪԴ£º£ºÖ×Áö·ÀÖÎÖÐÐÄ ±à¼­£º£ºÎâÁ¢¼á ÉóºË£º£ºËïÒ«±ó ÔĶÁÁ¿£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍø£¨Í¨Ñ¶Ô±ÕÔÏÖÍ¢£©¿ËÈÕ£¬£¬ £¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÕÅÁ¦½ÌÊÚÍŶÓǣͷ¿ªÕ¹¡¢ÌìÏÂ67¼ÒÑо¿ÖÐÐÄÅäºÏ¼ÓÈëµÄ¡°ÆÀ¼Û×¢ÉäÓÃHR20013ÓÃÓÚÔ¤·À¸ßÖÂÍÂÐÔ»¯ÁÆÒýÆð¶ñÐÄÍÂÄæµÄÓÐÓÃÐÔºÍÇå¾²ÐÔÑо¿¡ª¡ª¶àÖÐÐÄ¡¢Ëæ»ú¡¢Ë«Ã¤Ë«Ä£Äâ¡¢ÑôÐÔ±ÈÕÕ¢óÆÚÁÙ´²Ñо¿£¨PROFIT£©¡±ÔÚ¹ú¼Ê¶¥¼¶Ö×ÁöѧÆÚ¿¯¡¶ÁÙ´²Ö×ÁöѧÔÓÖ¾¡·£¨Journal of Clinical Oncology£©ÔÚÏß½ÒÏþ¡£¡£¡£Ñо¿Ð§¹ûÏÔʾ£¬£¬ £¬HR20013Ô¤·ÀÒÔ˳²¬Îª»ù´¡µÄ¸ßÖÂÍ»¯ÁƵ¼ÖµĶñÐÄÍÂÄæ£¨HEC-CINV£©ÏÔʾ³ö¾ßÓÐÔ¶¾°µÄÁÙ´²ÁÆÐ§¼°¿É¿ØµÄÇå¾²ÐÔ£¬£¬ £¬ÓÐÍûΪ´ËÀ໼ÕßÌṩÖÎÁÆÐÂÑ¡Ôñ¡£¡£¡£

ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÕÅÁ¦½ÌÊÚ¡¢»ÆÑÒÖ÷ÈÎҽʦΪ¸ÃÂÛÎĵÄÅäºÏͨѶ×÷Õß¡£¡£¡£ÖÜ»ªÇ¿Ö÷ÖÎҽʦ¡¢ÕÔæÂæÂÖ÷ÈÎҽʦΪ¸ÃÂÛÎÄÅäºÏµÚÒ»×÷Õß¡£¡£¡£

»¯ÁÆÏà¹ØÐÔ¶ñÐÄÍÂÄæ£¨CINV£©ÊÇ»¯ÁÆÀú³ÌÖÐ×î³£¼ûµÄ²»Á¼·´Ó³Ö®Ò»£¬£¬ £¬²»µ«Ê¹»¼Õß¶Ô»¯ÁƱ¬·¢¿Ö¾å£¬£¬ £¬»¹»á½µµÍÖÎÁÆÒÀ´ÓÐÔ£¬£¬ £¬´Ó¶øÓ°ÏìÉúÑÄ»ñÒæ¡£¡£¡£Ñо¿Åú×¢£¬£¬ £¬ÒÔ˳²¬Îª´ú±íµÄ¸ßÖÂÍÂÐÔ»¯ÁÆ¿Éʹ¼±ÐÔÍÂÄæµÄ±¬·¢ÂÊÁè¼Ý90%£¬£¬ £¬ÑÓ³ÙÐÔ¶ñÐÄÍÂÄæµÄ±¬·¢ÂÊÁè¼Ý50%¡£¡£¡£ÏÖÔÚ£¬£¬ £¬º£ÄÚÍâÖ¸ÄÏÕë¶Ô¸ß¶ÈÖÂÍÂÐÔ»¯ÁÆ£¨HEC£©Ïà¹ØCINVµÄÔ¤·À£¬£¬ £¬ÍƼöÒÔ5-ôÇÉ«°·3ÊÜÌåÞ׿¹¼Á£¨5-HT3 RA£©ºÍÉñ¾­¼¤ëÄÊÜÌå1Þ׿¹¼Á£¨NK-1RA£©Îª»ù´¡µÄÈýÁª/ËÄÁª·½°¸¡£¡£¡£È»¶ø£¬£¬ £¬ÁÙ´²ÉÏʹÓõÄÖ¹ÍÂÒ©´ó¶àÊǰëË¥ÆÚ½Ï¶ÌµÄÒ©Î£¬ £¬ÐèÒªºã¾Ã¡¢Öظ´¸øÒ©£¬£¬ £¬ÇÒ¶àÒ©ÁªºÏʹÓýÏÎªÖØ´ó£¬£¬ £¬µ¼Ö»¼ÕßÒÀ´ÓÐÔϽµ£¬£¬ £¬ÓÃÒ©·½°¸ÄÑÒÔÖ´ÐС£¡£¡£

Òò´Ë£¬£¬ £¬ÔõÑù¼ò»¯ÁÙ´²ÓÃÒ©£¬£¬ £¬Ìá¸ß»¼ÕßµÄÓÃÒ©ÒÀ´ÓÐÔ£¬£¬ £¬²¢Ò»´ÎÐÔÖÜÈ«¿ØÖÆÖ×Áö»¼Õß¼±ÐÔÆÚ£¨»¯Áƺó0-24h£©¡¢ÑÓ³ÙÆÚ£¨»¯Áƺó24-120h£©ÉõÖÁÊdz¬ÑÓ³ÙÆÚ£¨»¯Áƺó120-168h£©µÄCINV£¬£¬ £¬ÈÔÈ»ÊÇØ½´ý½â¾öµÄÁÙ´²ÎÊÌâ¡£¡£¡£

ÐÂÐ͸´·½Ö¹ÍÂÒ©HR20013ÓÉFosrolapitantºÍÅÁÂåŵ˾Çí×é³É£¬£¬ £¬FosrolapitantÔÚÌåÄÚ¿Éת»»ÎªÂÞÀ­Æ¥Ì¹¡£¡£¡£ÂÞÀ­Æ¥Ì¹ºÍÅÁÂåŵ˾ÇíµÄ°ëË¥ÆÚ»®·Ö³¤´ïÔ¼180СʱºÍ40Сʱ¡£¡£¡£HR20013Á¬ÏµÁËNK-1RAÂÞÀ­Æ¥Ì¹ºÍ¶þ´ú5-HT3RAÅÁÂåŵ˾ÇíµÄ³¬³¤°ëË¥ÆÚÓÅÊÆ¡£¡£¡£Ç°ÆÚÁÙ´²ÊÔÑéÅú×¢£¬£¬ £¬HR20013Äܹ»Í¬Ê±ÁýÕÖ¼±ÐÔÆÚ¡¢ÑÓ³ÙÆÚÒÔ¼°³¬ÑÓ³ÙÆÚ£¬£¬ £¬ÔÚÿ¸ö»¯ÁÆÖÜÆÚ½öÐèÓÃÒ©Ò»´Î£¬£¬ £¬¼´¿ÉÁýÕÖ³¤´ï7ÌìµÄCINV·çÏÕÆÚ£¬£¬ £¬¼«´ó¼ò»¯ÁËÓÃÒ©·½°¸£¬£¬ £¬Í¬Ê±¼æ¹ËÁËÇå¾²ÐÔ¡¢ÓÐÓÃÐԺͻ¼ÕßÒÀ´ÓÐÔ¡£¡£¡£È»¶ø£¬£¬ £¬¸ÃÒ©ÎïÔÚÔ¤·ÀHECÏà¹ØCINVµÄÓÐÓÃÐÔºÍÇå¾²ÐÔÈÔÐèͨ¹ý¸ü¸ßѭ֤ҽѧ֤¾Ý¾ÙÐнøÒ»²½ÑéÖ¤¡£¡£¡£

PROFITÑо¿ÊÇÒ»Ïî¶àÖÐÐÄ¡¢Ëæ»ú¡¢Ë«Ã¤¡¢Ë«Ä£Äâ¡¢ÑôÐÔ±ÈÕÕµÄIIIÆÚÁÙ´²Ñо¿£¨NCT05509634£©£¬£¬ £¬¹²Èë×é754Àýδ¾­»¯ÁƵĶñÐÔʵÌåÁö»¼Õߣ¬£¬ £¬ÆäÖÐ750Àý½ÓÊÜÒ©ÎïÖÎÁÆ¡£¡£¡£»£»¼ÕßËæ»ú·ÖΪÁ½×飬£¬ £¬ÔÚÿÖÜÆÚ¸øÓë˳²¬Îª»ù´¡µÄ¸ß¶ÈÖÂÍÂÐÔ»¯ÁÆ£¨Ë³²¬¼ÁÁ¿¡Ý60mg/m2£¬£¬ £¬IV£¬£¬ £¬D1£¬£¬ £¬Q3W£¬£¬ £¬¹²2¸öÖÜÆÚ£©Ç°£¬£¬ £¬»®·Ö½ÓÊÜÑо¿Ò©ÎïHR20013»ò¸£É³Æ¥Ì¹+ÅÁÂåŵ˾Çí£¨FAPR+PALO£©ÖÎÁÆ£¬£¬ £¬Í¬Ê±¿Ú·þµØÈûÃ×ËÉ£¨DEX£»£»D1-D4£©£¬£¬ £¬Á¬ÐøÊÓ²ìÁ½¸ö»¯ÁÆÖÜÆÚ¡£¡£¡£Ö÷ÒªÖÕµãÊǵÚ1¸ö»¯ÁÆÖÜÆÚ×ÜÌåÆÚ£¨0-120h£©ÍêÈ«»º½â£¨CR£©ÂÊ¡£¡£¡£Òªº¦´ÎÒªÖÕµãΪµÚ1¸ö»¯ÁÆÖÜÆÚ³¬ÑÓ³ÙÆÚÍêÈ«»º½âÂÊ¡£¡£¡£±ðµÄ£¬£¬ £¬¸ÃÑо¿»¹ÆÀ¹ÀÁË»¼ÕßµÄÉúÑÄÖÊÁ¿£¬£¬ £¬ÒÔ¶ÔÈÕ³£ÉúÑÄÎÞÓ°Ï죨NIDL£©µÄ»¼Õß±ÈÀý×÷ΪÆÀ¹ÀÒÀ¾Ý¡£¡£¡£ÔÚ»ùÏßÒÔ¼°×îÏÈʹÓø߶ÈÖÂÍÂÐÔ»¯ÁƵÄ24h¡¢120hºÍ168hºó»®·ÖÌîдÍÂÄæÉúÑĹ¦Ð§Á¿±í£¨FLIE£©Îʾí¡£¡£¡£NIDL½ç˵Ϊ×ÜÌåFLIEÆÀ·Ö>108»ò¶ñÐÄ/ÍÂÄæÆÀ·Ö>54¡£¡£¡£

Á½×黼Õß»ùÏßÌØÕ÷¾ßÓпɱÈÐÔ¡£¡£¡£HR20013+DEX×éºÍFAPR+PALO+DEX×é»®·ÖÓÐ373ÀýºÍ377Àý»¼Õß½ÓÊܵÚ1¸öÖÜÆÚµÄÑо¿ÖÎÁÆ£¬£¬ £¬314ÀýºÍ336Àý»¼Õß½ÓÊܵÚ2¸öÖÜÆÚµÄÑо¿ÖÎÁÆ¡£¡£¡£

µÚÒ»ÖÜÆÚ×ÜÌåÆÚµÄÍêÈ«»º½âÂÊ»®·ÖΪ77.7% vs 78.2%£¨²î±ðΪ-0.9%[95% CI:-6.7£¬£¬ £¬5.0]£»£»µ¥²àP<0.01£©£¬£¬ £¬ÏÔʾÖ÷ÒªÖÕµãµÖ´ï·ÇÁÓЧÐÔ£¨Í¼1£©¡£¡£¡£Í¬Ê±£¬£¬ £¬¸Ã¢óÆÚÁÙ´²Ñо¿Êý¾ÝÏÔʾ³öÁËHR20013ÔÚ³¬ÑÓ³ÙÆÚµÄÁÆÐ§£¬£¬ £¬ÎÞÂÛÊǵÚÒ»ÖÜÆÚÕվɵڶþÖÜÆÚ£¬£¬ £¬HR20013³¬ÑÓ³ÙÆÚÍêÈ«»º½âÂÊÊýÖµ¾ù¸ßÓÚFAPR+PALO£¨µÚÒ»ÖÜÆÚ£º£º90.3% vs 86.5%£»£»µÚ¶þÖÜÆÚ£º£º92.7% vs 87.8%£»£»Í¼1¡¢2£©¡£¡£¡£

45A796A347EA86E95ECC74BF833_5BCEB3B2_146ED

59CC4E28BAAA55B13B46D168544_B074EDAE_1C082

ÔÚ³¬ÑÓ³ÙÆÚ½×¶Î£¬£¬ £¬HR20013+DEX×éµÄÍêÈ«±£»£»¤ÂÊ£¨CP£»£»ÎÞÍÂÄæ/ÎÞÕü¾ÈÖÎÁÆ/ÎÞÏÔÖø¶ñÐÄ[ÊÓ¾õÄ£ÄâÁ¿±íµÃ·Ö<25mm]£©ºÍÍêÈ«¿ØÖÆÂÊ£¨TC£»£»ÎÞÍÂÄæ/ÎÞÕü¾ÈÖÎÁÆ/ÎÞ¶ñÐÄ[ÊÓ¾õÄ£ÄâÁ¿±íµÃ·Ö<5mm]£©ÊýÖµÉÏÓÅÓÚ±ÈÕÕ×飬£¬ £¬ÓÈÆäÊÇÔÚµÚ¶þÖÜÆÚ£¨CP£º£º90.8% vs 86.3%£»£»TC£º£º83.8% vs 78.6%£»£»Í¼3£©¡£¡£¡£

982ACD2288C4CE083D1DF8DB50F_BF3ED57C_24505

ÔÚµÚÒ»ÖÜÆÚµÄ3¸ö½×¶Î[¼±ÐÔÆÚ¡¢ÑÓ³ÙÆÚºÍ³¬ÑÓ³ÙÆÚ]ÖУ¬£¬ £¬Á½×éµÄ¶ÔÈÕ³£ÉúÑÄÎÞÓ°Ï죨NIDL£©»¼Õß±ÈÀýÔÚÕûÌåÓò¡¢¶ñÐÄÓòºÍÍÂÄæÓò¸ÅÂÔÏ൱£¨ËùÓеÄÃûÒåË«²àP>0.05£»£»Í¼4£©¡£¡£¡£ÔÚµÚ¶þÖÜÆÚÖУ¬£¬ £¬ÓëFAPR+PALO+DEX×éÏà±È£¬£¬ £¬HR20013+DEX×éµÄÕûÌåÓòÑÓ³ÙÆÚ£¨93.6% vs 87.8%£»£»ÃûÒåË«²àP=0.01£©¡¢ÍÂÄæÓòÑÓ³ÙÆÚ£¨95.2% vs 90.8%£»£»ÃûÒåË«²àP=0.03£©¡¢ÕûÌåÓò³¬ÑÓ³ÙÆÚ£¨96.8% vs 92.9%£»£»ÃûÒåË«²àP=0.03£©¡¢¶ñÐÄÓò³¬ÑÓ³ÙÆÚ£¨95.9% vs 91.1%£»£»ÃûÒåË«²àP=0.02£©¶ÔÈÕ³£ÉúÑÄÎÞÓ°Ï죨NIDL£©»¼Õß±ÈÀý¸ü¸ß£¨Í¼5£©¡£¡£¡£

CF7D6DAFAFA8B7EDB2F05E155CF_3E5F3349_18106

2B5818B2C861E98E7B5DC16D5CE_B28B02B9_19707

HR20013+DEX×éÖÎÁÆÏà¹Ø²»Á¼ÊÂÎñ£¨TRAEs£©µÄ±¬·¢ÂÊÔÚµÚÒ»ÖÜÆÚΪ35.7%£¬£¬ £¬ÔÚÕû¸öÑо¿Ê±´úΪ42.1%£¬£¬ £¬¶øFAPR+PALO+DEX×é»®·ÖΪ38.2%ºÍ44.0%¡£¡£¡£ÔÚÕû¸öÑо¿Ê±´ú£¬£¬ £¬×î³£¼ûµÄ²»Á¼·´Ó³ÊDZãÃØ£¨HR20013+DEX:10.7%£¬£¬ £¬FAPR+PALO+DEX:14.3%£©ºÍßÀÄæ£¨HR20013+ DEX:7.5%£¬£¬ £¬FAPR+PALO+DEX:11.4%£©¡£¡£¡£

Ñо¿Ð§¹ûÏÔʾ£¬£¬ £¬HR20013+DEXÔÚÔ¤·À¶ñÐÄÍÂÄæµÄÁÆÐ§²»ÁÓÓÚFAPR+PALO+DEX£¬£¬ £¬²¢ÇÒ¾ßÓÐÓÅÒìµÄÇå¾²ÐÔ¡£¡£¡£±ðµÄ£¬£¬ £¬Ñо¿»¹·¢Ã÷HR20013+DEX¿ÉÄÜÔÚ³¬ÑÓ³ÙÆÚÌá¸ßÁÙ´²»ñÒæ¡£¡£¡£ÓëFAPR+PALO+DEXÏà±È£¬£¬ £¬HR20013+DEXÔÚ½ÓÊÜHEC»¯ÁƵϼÕßÖÐÏÔʾ³ö¸ÄÉÆÉúÑÄÖÊÁ¿µÄDZÁ¦£¬£¬ £¬ÓÈÆäÊÇÔÚÑÓ³ÙÆÚºÍ³¬ÑÓ³ÙÆÚ¡£¡£¡£

»ùÓÚHR20013ÔÚÔ¤·À¸ßÖÂÍ»¯ÁƵ¼ÖµĶñÐÄÍÂÄæ£¨HEC-CINV£©È¡µÃµÄÓÅÒìЧ¹û£¬£¬ £¬ÏÖÔÚ¸ÃÁ¢ÒìÒ©ÎïµÄÊ×Åú˳Ӧ֢ÉÏÊÐÉêÇëÒѱ»¹ú¼ÒÒ©Æ·ÉóÆÀÖÐÐÄ£¨CDE£©ÊÜÀí¡£¡£¡£

ÂÛÎÄÁ´½Ó£º£º

https://ascopubs.org/doi/10.1200/JCO-24-01308


¡¾ÍøÕ¾µØÍ¼¡¿